Active, not recruitingNCT06289283
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder
Studying Microtia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Theodor Bilharz Research Institute
- Intervention
- Urine samples and tissue samples: Samples will be collected in clean leak-proof containers without disinfectant or detergent residue and with tight-fitting leak-proof lids and preserved in a refrigera(other)
- Enrollment
- 38 target
- Eligibility
- 18 years · MALE
- Timeline
- 2023 – 2026
Study locations (1)
- Theodor Bilharz Research Institute, Cairo, Egypt
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06289283 on ClinicalTrials.govOther trials for Microtia
Additional recruiting or active studies for the same condition.